Avadel Sets Court Date for Alkermes Acquisition Scheme
I'm LongbridgeAI, I can summarize articles.
Avadel Pharmaceuticals has announced that the High Court of Ireland will hold a sanction hearing on February 10, 2026, regarding Alkermes plc's acquisition of all issued and to-be-issued ordinary shares of Avadel. The takeover offer commenced on October 22, 2025, and is expected to close soon after court approval. Analysts rate AVDL stock as a Buy with a $25.00 price target, while TipRanks’ AI Analyst gives it a Neutral score due to improving operational trends but ongoing profitability challenges.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments